Report Scope
This report aims to provide a comprehensive presentation of the global market for Tacrolimus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tacrolimus.
The Tacrolimus market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tacrolimus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tacrolimus manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GSK
Abbott
Roche Pharma
Novartis
Mylan
Squibb
Astellas
Aarti Group
Takeda
Huapont Pharma
Senju Pharmaceutical
Guike Pharmaceutical
Tecoland
Sandoz
ScinoPharm
RPG Life Science
Suzhou Pharmaceutical Technology
Accura Pharmaceuticals
Fujisawa Pharmaceutical
Sichuan Med-Shine Pharmaceutical
Sinopharm Chuankang Pharmaceutical
Yamanouchi Pharmaceutical
Zhongmei Huadong Pharmaceutical
Hisun Pharmaceutical
Segment by Type
Tacrolimus Capsules
Tacrolimus Ointment
Tacrolimus Injection
Segment by Application
Hospitals
Clinics
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tacrolimus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tacrolimus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Tacrolimus Market Overview
1.1 Product Definition
1.2 Tacrolimus by Type
1.2.1 Global Tacrolimus Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tacrolimus Capsules
1.2.3 Tacrolimus Ointment
1.2.4 Tacrolimus Injection
1.3 Tacrolimus by Application
1.3.1 Global Tacrolimus Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Tacrolimus Market Size Estimates and Forecasts
1.4.1 Global Tacrolimus Revenue 2020-2031
1.4.2 Global Tacrolimus Sales 2020-2031
1.4.3 Global Tacrolimus Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tacrolimus Market Competition by Manufacturers
2.1 Global Tacrolimus Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tacrolimus Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tacrolimus Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tacrolimus, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tacrolimus, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tacrolimus, Product Type & Application
2.7 Global Key Manufacturers of Tacrolimus, Date of Enter into This Industry
2.8 Global Tacrolimus Market Competitive Situation and Trends
2.8.1 Global Tacrolimus Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tacrolimus Players Market Share by Revenue
2.8.3 Global Tacrolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tacrolimus Market Scenario by Region
3.1 Global Tacrolimus Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tacrolimus Sales by Region: 2020-2031
3.2.1 Global Tacrolimus Sales by Region: 2020-2025
3.2.2 Global Tacrolimus Sales by Region: 2026-2031
3.3 Global Tacrolimus Revenue by Region: 2020-2031
3.3.1 Global Tacrolimus Revenue by Region: 2020-2025
3.3.2 Global Tacrolimus Revenue by Region: 2026-2031
3.4 North America Tacrolimus Market Facts & Figures by Country
3.4.1 North America Tacrolimus Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tacrolimus Sales by Country (2020-2031)
3.4.3 North America Tacrolimus Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tacrolimus Market Facts & Figures by Country
3.5.1 Europe Tacrolimus Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tacrolimus Sales by Country (2020-2031)
3.5.3 Europe Tacrolimus Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tacrolimus Market Facts & Figures by Region
3.6.1 Asia Pacific Tacrolimus Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tacrolimus Sales by Region (2020-2031)
3.6.3 Asia Pacific Tacrolimus Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tacrolimus Market Facts & Figures by Country
3.7.1 Latin America Tacrolimus Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tacrolimus Sales by Country (2020-2031)
3.7.3 Latin America Tacrolimus Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tacrolimus Market Facts & Figures by Country
3.8.1 Middle East and Africa Tacrolimus Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tacrolimus Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tacrolimus Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tacrolimus Sales by Type (2020-2031)
4.1.1 Global Tacrolimus Sales by Type (2020-2025)
4.1.2 Global Tacrolimus Sales by Type (2026-2031)
4.1.3 Global Tacrolimus Sales Market Share by Type (2020-2031)
4.2 Global Tacrolimus Revenue by Type (2020-2031)
4.2.1 Global Tacrolimus Revenue by Type (2020-2025)
4.2.2 Global Tacrolimus Revenue by Type (2026-2031)
4.2.3 Global Tacrolimus Revenue Market Share by Type (2020-2031)
4.3 Global Tacrolimus Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tacrolimus Sales by Application (2020-2031)
5.1.1 Global Tacrolimus Sales by Application (2020-2025)
5.1.2 Global Tacrolimus Sales by Application (2026-2031)
5.1.3 Global Tacrolimus Sales Market Share by Application (2020-2031)
5.2 Global Tacrolimus Revenue by Application (2020-2031)
5.2.1 Global Tacrolimus Revenue by Application (2020-2025)
5.2.2 Global Tacrolimus Revenue by Application (2026-2031)
5.2.3 Global Tacrolimus Revenue Market Share by Application (2020-2031)
5.3 Global Tacrolimus Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Tacrolimus Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Tacrolimus Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Roche Pharma
6.3.1 Roche Pharma Company Information
6.3.2 Roche Pharma Description and Business Overview
6.3.3 Roche Pharma Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Pharma Tacrolimus Product Portfolio
6.3.5 Roche Pharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Tacrolimus Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Tacrolimus Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Squibb
6.6.1 Squibb Company Information
6.6.2 Squibb Description and Business Overview
6.6.3 Squibb Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Squibb Tacrolimus Product Portfolio
6.6.5 Squibb Recent Developments/Updates
6.7 Astellas
6.7.1 Astellas Company Information
6.7.2 Astellas Description and Business Overview
6.7.3 Astellas Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Astellas Tacrolimus Product Portfolio
6.7.5 Astellas Recent Developments/Updates
6.8 Aarti Group
6.8.1 Aarti Group Company Information
6.8.2 Aarti Group Description and Business Overview
6.8.3 Aarti Group Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Aarti Group Tacrolimus Product Portfolio
6.8.5 Aarti Group Recent Developments/Updates
6.9 Takeda
6.9.1 Takeda Company Information
6.9.2 Takeda Description and Business Overview
6.9.3 Takeda Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Takeda Tacrolimus Product Portfolio
6.9.5 Takeda Recent Developments/Updates
6.10 Huapont Pharma
6.10.1 Huapont Pharma Company Information
6.10.2 Huapont Pharma Description and Business Overview
6.10.3 Huapont Pharma Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Huapont Pharma Tacrolimus Product Portfolio
6.10.5 Huapont Pharma Recent Developments/Updates
6.11 Senju Pharmaceutical
6.11.1 Senju Pharmaceutical Company Information
6.11.2 Senju Pharmaceutical Description and Business Overview
6.11.3 Senju Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Senju Pharmaceutical Tacrolimus Product Portfolio
6.11.5 Senju Pharmaceutical Recent Developments/Updates
6.12 Guike Pharmaceutical
6.12.1 Guike Pharmaceutical Company Information
6.12.2 Guike Pharmaceutical Description and Business Overview
6.12.3 Guike Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Guike Pharmaceutical Tacrolimus Product Portfolio
6.12.5 Guike Pharmaceutical Recent Developments/Updates
6.13 Tecoland
6.13.1 Tecoland Company Information
6.13.2 Tecoland Description and Business Overview
6.13.3 Tecoland Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Tecoland Tacrolimus Product Portfolio
6.13.5 Tecoland Recent Developments/Updates
6.14 Sandoz
6.14.1 Sandoz Company Information
6.14.2 Sandoz Description and Business Overview
6.14.3 Sandoz Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sandoz Tacrolimus Product Portfolio
6.14.5 Sandoz Recent Developments/Updates
6.15 ScinoPharm
6.15.1 ScinoPharm Company Information
6.15.2 ScinoPharm Description and Business Overview
6.15.3 ScinoPharm Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.15.4 ScinoPharm Tacrolimus Product Portfolio
6.15.5 ScinoPharm Recent Developments/Updates
6.16 RPG Life Science
6.16.1 RPG Life Science Company Information
6.16.2 RPG Life Science Description and Business Overview
6.16.3 RPG Life Science Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.16.4 RPG Life Science Tacrolimus Product Portfolio
6.16.5 RPG Life Science Recent Developments/Updates
6.17 Suzhou Pharmaceutical Technology
6.17.1 Suzhou Pharmaceutical Technology Company Information
6.17.2 Suzhou Pharmaceutical Technology Description and Business Overview
6.17.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio
6.17.5 Suzhou Pharmaceutical Technology Recent Developments/Updates
6.18 Accura Pharmaceuticals
6.18.1 Accura Pharmaceuticals Company Information
6.18.2 Accura Pharmaceuticals Description and Business Overview
6.18.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Accura Pharmaceuticals Tacrolimus Product Portfolio
6.18.5 Accura Pharmaceuticals Recent Developments/Updates
6.19 Fujisawa Pharmaceutical
6.19.1 Fujisawa Pharmaceutical Company Information
6.19.2 Fujisawa Pharmaceutical Description and Business Overview
6.19.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Fujisawa Pharmaceutical Tacrolimus Product Portfolio
6.19.5 Fujisawa Pharmaceutical Recent Developments/Updates
6.20 Sichuan Med-Shine Pharmaceutical
6.20.1 Sichuan Med-Shine Pharmaceutical Company Information
6.20.2 Sichuan Med-Shine Pharmaceutical Description and Business Overview
6.20.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio
6.20.5 Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
6.21 Sinopharm Chuankang Pharmaceutical
6.21.1 Sinopharm Chuankang Pharmaceutical Company Information
6.21.2 Sinopharm Chuankang Pharmaceutical Description and Business Overview
6.21.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio
6.21.5 Sinopharm Chuankang Pharmaceutical Recent Developments/Updates
6.22 Yamanouchi Pharmaceutical
6.22.1 Yamanouchi Pharmaceutical Company Information
6.22.2 Yamanouchi Pharmaceutical Description and Business Overview
6.22.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio
6.22.5 Yamanouchi Pharmaceutical Recent Developments/Updates
6.23 Zhongmei Huadong Pharmaceutical
6.23.1 Zhongmei Huadong Pharmaceutical Company Information
6.23.2 Zhongmei Huadong Pharmaceutical Description and Business Overview
6.23.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio
6.23.5 Zhongmei Huadong Pharmaceutical Recent Developments/Updates
6.24 Hisun Pharmaceutical
6.24.1 Hisun Pharmaceutical Company Information
6.24.2 Hisun Pharmaceutical Description and Business Overview
6.24.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Hisun Pharmaceutical Tacrolimus Product Portfolio
6.24.5 Hisun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tacrolimus Industry Chain Analysis
7.2 Tacrolimus Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tacrolimus Production Mode & Process Analysis
7.4 Tacrolimus Sales and Marketing
7.4.1 Tacrolimus Sales Channels
7.4.2 Tacrolimus Distributors
7.5 Tacrolimus Customer Analysis
8 Tacrolimus Market Dynamics
8.1 Tacrolimus Industry Trends
8.2 Tacrolimus Market Drivers
8.3 Tacrolimus Market Challenges
8.4 Tacrolimus Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
The global Tacrolimus market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 115
USD 2900.00
(Single User License)
The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 167
USD 3950.00
(Single User License)
The global Tacrolimus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-22
Pages: 127
USD 4900.00
(Single User License)
The global market for Tacrolimus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 151
USD 3950.00
(Single User License)
The global Tacrolimus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 117
USD 4250.00
(Single User License)
The global Tacrolimus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 147
USD 2900.00
(Single User License)
The global market for Tacrolimus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 158
USD 3950.00
(Single User License)
The global Tacrolimus market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 115
The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 167
The global Tacrolimus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-22
Pages: 127
The global market for Tacrolimus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 151
The global Tacrolimus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 117
The global Tacrolimus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 147
The global market for Tacrolimus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 158
REPORT COVERAGE
Report Scope
Chapter Outline
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research